El-Nashar, H.A.S.; Abbas, H.; Zewail, M.; Noureldin, M.H.; Ali, M.M.; Shamaa, M.M.; Khattab, M.A.; Ibrahim, N.
Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways. Pharmaceuticals 2022, 15, 1202.
https://doi.org/10.3390/ph15101202
AMA Style
El-Nashar HAS, Abbas H, Zewail M, Noureldin MH, Ali MM, Shamaa MM, Khattab MA, Ibrahim N.
Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways. Pharmaceuticals. 2022; 15(10):1202.
https://doi.org/10.3390/ph15101202
Chicago/Turabian Style
El-Nashar, Heba A. S., Haidy Abbas, Mariam Zewail, Mohamed H. Noureldin, Mai M. Ali, Marium M. Shamaa, Mohamed A. Khattab, and Nehal Ibrahim.
2022. "Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways" Pharmaceuticals 15, no. 10: 1202.
https://doi.org/10.3390/ph15101202
APA Style
El-Nashar, H. A. S., Abbas, H., Zewail, M., Noureldin, M. H., Ali, M. M., Shamaa, M. M., Khattab, M. A., & Ibrahim, N.
(2022). Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways. Pharmaceuticals, 15(10), 1202.
https://doi.org/10.3390/ph15101202